Zobrazeno 1 - 10
of 147
pro vyhledávání: '"HFrEF—heart failure with reduced ejection fraction"'
Autor:
Mutaz Alkalbani, Mitchell A. Psotka
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
The Heart Failure Collaboratory (HFC) is a consortium of stakeholders in the heart failure (HF) community that aims to improve the infrastructure of clinical research to promote development of novel therapies for patients. Since its launch in 2018, H
Externí odkaz:
https://doaj.org/article/b3ed23d2c1e24de8b78122f35b185ad2
Autor:
Yahe Xu, Mingjie Zhang, Yijun Chen, Xi Chen, Wenting Song, Limin Zhu, Liping Liu, Xiaolei Gong, Yuqi Zhang, Zhuoming Xu
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundSacubitril/valsartan is an angiotensin receptor neprilysin antagonist (ARNI) approved for adult heart failure (HF). Its safety and efficacy in pediatric HF patients with cardiomyopathy or congenital heart disease are poorly understood. A pi
Externí odkaz:
https://doaj.org/article/5fcb75a1815b4306890c2efefe5c70e1
Autor:
Chenshan Gao, Lei Hou
Publikováno v:
Frontiers in Nutrition, Vol 10 (2023)
As a terminal stage of various cardiovascular diseases, heart failure is of great concern due to its high mortality rate and limited treatment options. Researchers are currently focusing their efforts on investigating the metabolism of carbohydrates,
Externí odkaz:
https://doaj.org/article/58464ad34c074811a5b8009d187beb5c
Autor:
Shiqun Chen, Zhidong Huang, Yan Liang, Xiaoli Zhao, Xiemuxikaimaier Aobuliksimu, Bo Wang, Yibo He, Yu Kang, Haozhang Huang, Qiang Li, Younan Yao, Xiaozhao Lu, Xiaoxian Qian, Xujing Xie, Jin Liu, Yong Liu
Publikováno v:
ESC Heart Failure, Vol 9, Iss 4, Pp 2336-2347 (2022)
Abstract Aims Available evidence is incomplete and inconsistent in the outcomes of heart failure (HF) patients with preserved ejection fraction (HFpEF), mildly reduced ejection fraction (HFmrEF), and reduced ejection fraction (HFrEF). There are also
Externí odkaz:
https://doaj.org/article/14bc7c39d37242ec87299bb8fb514f3e
Publikováno v:
Frontiers in Physiology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/315fd060b4134f7c81affc6d1c014a1f
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
Lack of significant advancements in early detection and treatment of heart failure have precipitated the need for discovery of novel biomarkers and therapeutic targets. Over the past decade, circulating sphingolipids have elicited promising results a
Externí odkaz:
https://doaj.org/article/05aeba4e8d51413f9f584cf240481187
Autor:
Anne Bingel, Daniel Messroghli, Andreas Weimar, Kilian Runte, Maximilian Salcher-Konrad, Sebastian Kelle, Burkert Pieske, Felix Berger, Titus Kuehne, Leonid Goubergrits, Daniel Fuerstenau, Marcus Kelm
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Although disease etiologies differ, heart failure patients with preserved and reduced ejection fraction (HFpEF and HFrEF, respectively) both present with clinical symptoms when under stress and impaired exercise capacity. The extent to which the adap
Externí odkaz:
https://doaj.org/article/6be771813e374bee9ed8570d9db49080
Publikováno v:
Indian Heart Journal, Vol 72, Iss 1, Pp 27-31 (2020)
Background: Acute decompensated heart failure (ADHF) is a growing public health problem in the community. Limited and often contradictory data are available from small studies published from India. Objective of this study was to report clinical chara
Externí odkaz:
https://doaj.org/article/c6599b5257324e449fee4c57f83029bd
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
BackgroundObstructive sleep apnea (OSA) is a potential risk factor in cardiovascular diseases, including arrhythmia, coronary artery disease, and heart failure (HF). Continuous positive airway pressure (CPAP) therapy is an effective therapy for OSA a
Externí odkaz:
https://doaj.org/article/9c9e4b77cc9c4477a86a8622ab96ef3a
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2022)
BackgroundPrevious studies have reported inconsistent results regarding the implications of deranged insulin-like growth factor 1 (IGF-1)/insulin-like growth factor-binding protein 1 (IGFBP-1) axis in patients with heart failure (HF). This study eval
Externí odkaz:
https://doaj.org/article/710c2b03c809405f81af5934bc4ba750